Home Clinical Topics FDA approves new treatment for rare bile acid synthesis disorders

FDA approves new treatment for rare bile acid synthesis disorders

On March 17, the U.S. Food and Drug Administration (FDA) approved Cholbam (cholic acid) capsules, the first FDA-approved treatment for pediatric and adult patients with bile acid synthesis disorders due to single enzyme defects, and for patients with peroxisomal disorders (including Zellweger spectrum disorders. Read more.

LEAVE A REPLY

Please enter your comment!
Please enter your name here